ScoreWhy is Insmed, Inc. ?
1
- NET PROFIT(HY) Higher at USD -523.81 MM
- INVENTORY TURNOVER RATIO(HY) Highest at 1.12 times
- RAW MATERIAL COST(Y) Fallen by -12.04% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 91.12%, its profits have fallen by -38.4%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Consistent Returns over the last 3 years
- Along with generating 91.12% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Insmed, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Insmed, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Insmed, Inc.
96.87%
2.65
52.36%
S&P 500
17.78%
0.92
19.35%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.83%
EBIT Growth (5y)
-211.85%
EBIT to Interest (avg)
-10.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.79
Sales to Capital Employed (avg)
0.28
Tax Ratio
0.40%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
28.40
EV to EBIT
-37.03
EV to EBITDA
-37.53
EV to Capital Employed
324.13
EV to Sales
86.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-875.41%
ROE (Latest)
-76.35%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend23What is working for the Company
NET PROFIT(HY)
Higher at USD -523.81 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.12 times
RAW MATERIAL COST(Y)
Fallen by -12.04% (YoY
CASH AND EQV(HY)
Highest at USD 3,110.03 MM
NET SALES(Q)
Highest at USD 263.84 MM
OPERATING PROFIT MARGIN(Q)
Highest at -92.53 %
-6What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -935.02 MM
ROCE(HY)
Lowest at -249.28%
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.29 times
Here's what is working for Insmed, Inc.
Net Sales
At USD 263.84 MM has Grown at 136.09%
over average net sales of the previous four periods of USD 111.76 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Net Profit
Higher at USD -523.81 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 1.12 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
Highest at USD 263.84 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit Margin
Highest at -92.53 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Cash and Eqv
Highest at USD 3,110.03 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -12.04% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 5.56 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Depreciation
At USD 5.56 MM has Grown at 39.16%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (USD MM)
Here's what is not working for Insmed, Inc.
Operating Cash Flow
Lowest at USD -935.02 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Lowest at 6.29 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
